Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026

gaudium® IVF Delivering Motherhood Dreams August 13, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Exchange Plaza, C-1, Block G, Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai — 400001, Maharashtra Mumbai — 400051, Maharashtra Scrip Code — 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Dear Sir/Madam, Subject: Outcome of the Board Meeting held on August 13, 2026. Ref: Disclosures pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors (“Board”) of Gaudium IVF and Women Health Limited (“Company”), at its meeting held on August 13, 2026 i.e. today has, inter alia, considered and approved the following matters: 1. Approved the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026 ( “Unaudited Financial Results”). The copy of the Unaudited Financial Results along with the Limited Review Report received from the Statutory Auditors, M/s. S K G N & Associates LLP, Chartered Accountants, is enclosed herewith as ‘Annexure A’. 2. Based on the recommendation of the Audit Committee, the Board has approved the Re-appointment of Ram Rattan & Associates as the Internal Auditor of the Company for the Financial Year 2026-27. The details required under Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations and the SEBI Master circular HO/49/14/14(7)2025- CFD-POD2/1/3762/2026 dated January 30, 2026, is annexed herewith as ‘Annexure B’. 3. Based on the recommendation of the Audit Committee and subject to approval of the shareholders of the Company at the ensuing Annual General Meeting, the Board has approved the appointment of M/s. Suresh Nainwal & Company, Practicing Company Secretaries (Firm Registration No. S2020DE764700, Peer reviewed No.: 3349/2023) as a Secretarial Auditor of the Company for a term of 5 (five) consecutive years commencing from the FY 2026-27 to FY 2030-31. The details required under Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations and the SEBI Master circular HO/49/14/14(7)2025- CFD-POD2/1/3762/2026 dated January 30, 2026, is annexed herewith as ‘Annexure C’. Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com [l gaudium® IVF Delivering Motherhood Dreams 4. The statement of Deviation(s) or Variation(s), pursuant to Regulation 32 of the SEBI Listing Regulations read with SEBI Master circular HO/49/14/14(7)2025- CFD-POD2/1/3762/2026 dated January 30, 2026, regarding the utilization of funds raised through Initial Public Offer (“IPO”) for the quarter ended June 30, 2026, is enclosed herewith as ‘Annexure D’. 5. The 11th AGM of the Company is scheduled to be held on Monday, September 28, 2026, through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). The Notice convening the AGM will be circulated to Shareholders within the prescribed statutory timeline. This disclosure will also be hosted on the website of the Company at www.gaudiumivfcentre.com We request you to please take the same on record and arrange to bring this to the notice of all concerned. The Board meeting commenced at 03:30 P.M. and concluded at 05:30 P.M. Thanking you, Yours faithfully. For and on behaloff Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No.: A69788 Encl.: a/a Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com [l SKGN& Associates £ i mine KUNE INDIA Chartered Accountants Independent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Gaudium IVF and Women Health Limited (formerly known as Gaudium IVF and Women Health Private Limited) 1. We have reviewed the accompanying statement of unaudited standalone financial results of Gaudium IVF and Women Health Limited (formerly known as Gaudium IVF and Women Health Private Limited) (the “Company”) for the quarter ended June 30, 2026 (the “Statement”) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). 2. The Company's Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS 34), “Interim Financial Reporting” prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Sia SRUETOR Office No. 1126, Tower B, |-Thum Commercial Complex, Sector-62, Noida-201309, Uttar Pradesh, India Ph : +91 89290-05961, E-mail : office@skgn.in, Website : www.skgnindia.com 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (‘Ind AS’) specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. We have not reviewed the accompanying financial results and other financial information for the quarter ended June 30, 2025 which has been presented solely based on the information compiled by the management. Our conclusion on the Statement is not modified in respect of the above matter. 6. The figures for the three months ended March 31, 2026 as reported in the Statement are. the balancing figures between audited figures in respect off ull previous financial year and the published year to date figures up to the third quar [Showing first 8,000 characters — download PDF for full document]